Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.
Longstanding commercial medtech and diagnostic experience added to the Inmedix executive team NORMANDY PARK, WA, USA, January 20, 2024 /EINPresswire.com/ — Seattle-based medtech/biotech Inmedix, Inc., developers of immuno-autonomics and cloud-based clinical diagnostics to quantify stress biology with precision, announced today the appointment of Lucy Lu as its Chief Commercial Officer (CCO). Lucy Lu has more…
Read More “Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.” »
